Correlation Between Olema Pharmaceuticals and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Olema Pharmaceuticals and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Olema Pharmaceuticals and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Olema Pharmaceuticals and C4 Therapeutics, you can compare the effects of market volatilities on Olema Pharmaceuticals and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Olema Pharmaceuticals with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Olema Pharmaceuticals and C4 Therapeutics.
Diversification Opportunities for Olema Pharmaceuticals and C4 Therapeutics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Olema and CCCC is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Olema Pharmaceuticals and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Olema Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Olema Pharmaceuticals are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Olema Pharmaceuticals i.e., Olema Pharmaceuticals and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Olema Pharmaceuticals and C4 Therapeutics
Given the investment horizon of 90 days Olema Pharmaceuticals is expected to generate 2.26 times less return on investment than C4 Therapeutics. But when comparing it to its historical volatility, Olema Pharmaceuticals is 2.04 times less risky than C4 Therapeutics. It trades about 0.04 of its potential returns per unit of risk. C4 Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 348.00 in C4 Therapeutics on September 1, 2024 and sell it today you would earn a total of 107.00 from holding C4 Therapeutics or generate 30.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Olema Pharmaceuticals vs. C4 Therapeutics
Performance |
| Timeline |
| Olema Pharmaceuticals |
| C4 Therapeutics |
Olema Pharmaceuticals and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Olema Pharmaceuticals and C4 Therapeutics
The main advantage of trading using opposite Olema Pharmaceuticals and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Olema Pharmaceuticals position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |